Sarepta Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 72 U.S.-traded ETFs. SRPT has around 6.6M shares in the U.S. ETF market. The largest ETF holder of SRPT is the First Trust NYSE Arca Biotechnology Index Fund (FBT), with approximately 929.83K shares. Investors may also find of interest that the ETF with the largest allocation to SRPT stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 4.43%. On average, U.S. ETFs allocate 0.35% of SRPT to their portfolios.
Additionally, SRPT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SRPT as a holding is the Invesco RAFI Strategic US Small Company ETF (IUSS), with a return of 69.76%.